#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Castleman's disease Juvenile idiopathic arthritis Scleroderma associated digital ulcer Acute on chronic liver failure Myeloid leukaemia Osteopetrosis Vulval cancer Osteosarcoma Usher's syndrome Squamous cell carcinoma of the hypopharynx Neuroendocrine carcinoma of the skin Ewing's sarcoma metastatic Malignant neoplasm of choroid Waldenstrom's macroglobulinaemia refractory Acute hepatic failure More trials…

    Learn about Rare Diseases

    Epidermolysis bullosa – Life with Disease Chordoma – Life with Disease Rett syndrome – Diagnostics Richter’s syndrome – Basic Information Proteus syndrome – Life with Disease Lysosomal storage disorder – Life with Disease Uterine leiomyosarcoma – Life with Disease Ewing’s sarcoma recurrent Testicular leiomyosarcoma – Life with Disease Castleman’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk4381562A Stro-002 Contezolid Depemokimab Incb099280 Transpocart19 VAMIFEPORT TRIHYDROCHLORIDE Linezolid Imgn151 Sodium Iotalamate (125I) Prednisolone Trientine Dihydrochloride Enomimeran Aciclovir Gelatin Methotrexate Cl-Ad-Msc-002 SALICYLIC ACID Pimozide Rezvilutamide More therapies…

    Learn about Your Condition

    Friedreich's ataxia Systemic sclerosis pulmonary Femoral neck fracture Reperfusion injury Pleomorphic liposarcoma Chronic sinusitis Critical illness Dengue fever Cardiac sarcoidosis Undifferentiated sarcoma Renal failure Neoplasm malignant Autoimmune uveitis Glucose tolerance impaired Peripheral artery thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps

    Not recruiting

    2 1 1
    Investigated Drugs:
    • BRENSOCATIB
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study of ISIS 678354 for Patients with Severe High Triglycerides

    Not recruiting

    3 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia France Greece Hungary +9

  • Study on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma

    Not recruiting

    2 1
    Investigated Drugs:
    • GSK5784283
    Bulgaria Czechia Germany Romania Spain

  • Title: Study of Sibeprenlimab Treatment for Adults with Sjögren’s Disease Using Subcutaneous Injections

    Not recruiting

    2 1
    Investigated Drugs:
    • Sibeprenlimab
    Bulgaria Germany Greece Poland Romania Spain

  • Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Estonia France Germany +12

  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sonelokimab
    • Risankizumab
    Bulgaria Czechia France Germany Hungary Poland +1

  • Study of meropenem-vaborbactam safety and effectiveness in children aged 3 months to 12 years with complicated urinary tract infection or acute pyelonephritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Urinary tract infection
    • Pyelonephritis acute
    Investigated Drugs:
    • Meropenem
    • Vaborbactam
    Belgium Bulgaria Croatia Greece Poland Spain

  • Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Quizartinib Dihydrochloride
    • Idarubicin Hydrochloride
    • Daunorubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia France +9

  • Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10

  • Study on Fentanyl Nasal Spray and Morphine for Managing Postoperative Pain in Patients After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fentanyl Citrate
    • Placebo
    Bulgaria Germany
Previous Page
1 … 10 11 12 13 14 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!